Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

In this issue

Insight

Illustration showing diabetes and heart disease

The cholesterol and calorie hypotheses are both dead — it is time to focus on the real culprit: insulin resistance

By , ,

Emerging evidence shows that insulin resistance is the most important predictor of cardiovascular and type 2 diabetes.

CPD article

Micrograph of non-alcoholic fatty liver (NAFL)

Non-alcoholic fatty liver disease and diabetes: diagnosis, assessment and management

By

Non-alcoholic fatty liver disease is the term for a range of conditions caused by a build-up of fat in the liver. The condition is thought to be highly prevalent; however, the dearth of symptoms during early disease and the lack of a specific diagnostic test make it difficult to detect and manage at an early stage. This presents a considerable challenge for healthcare professionals.

Review

Transmission Electron Micrograph view (TEM) of Hepatitis B virus

An update on the management of chronic hepatitis B and C infectionSubscription

By , , , ,

Chronic hepatitis B and C infection are leading causes of liver-related morbidity and mortality worldwide. Current therapies for chronic hepatitis B virus (HBV) infection consisting of nucleos(t)ide analogues (NA) rarely lead to functional cure. With a better understanding of the HBV lifecycle, novel agents have been developed with the hope of achieving functional cure. The development of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) therapy has led to ...

Short communications

Shortsighted decision not to recommend HPV vaccination for boysSubscription

By

The Joint Committee for Vaccine and Immunisation (JCVI) has recently announced that the vaccine that could stop people from dying from human papilloma virus (HPV)-related cancers will not be given to boys (The Pharmaceutical Journal online, 20 July 2017).

Charcoal toothpastes: what we know so farSubscription

By ,

Charcoal toothpastes are a recent innovation in the oral healthcare product market, and some pharmacies have started stocking them. The marketing campaigns for these toothpastes are fashionable, trendy, and different to those for other toothpastes. This marketing has enjoyed considerable success, encouraging the introduction of related products, including ‘charcoal toothbrushes’, which have charcoal incorporated into the bristles.

Knowledge on formulations is vital for clinical practiceSubscription

By

As pharmacy moves forward, there will no doubt be necessary changes to the undergraduate pharmacy curriculum. However, we must ensure that the foundation knowledge that all pharmacists should have is not compromised. The pharmacist, in some instances, is all that stands between the patient and harm from their medicines. This may mean counselling in the correct use of their medicines, but it also means knowing the limitations of types of dosage forms.

Experience of setting up and running a referral scheme from the secondary care anticoagulant clinic to community pharmacies in SwindonSubscription

By , ,

The new medicines service (NMS) is an advanced service in the community pharmacy contractual framework. It consists of community pharmacist structured interviews with patients during their first month of treatment with a new medicine. The service aims to improve medicines concordance and improve patient understanding of their treatment.

Pharmaceutical Journal Jobs

More jobs

Clinical Pharmacist

Clinical Pharmacist cover - August 2017

CP August 2017, Vol 9, No 8

Cover Story:

An update on the management of chronic hepatitis B and C infection

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.